Centre for Cardiovascular Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
J Thromb Haemost. 2013 Sep;11(9):1663-8. doi: 10.1111/jth.12332.
The ISTH bleeding assessment tool (ISTH-BAT) was developed to record bleeding symptoms and to aid diagnosis in patients with a possible bleeding disorder.
To investigate the utility of the ISTH-BAT in predicting functional defects in platelet activation in participants with suspected inherited platelet function disorders.
PATIENTS/METHODS: Participants with clinical evidence of excessive bleeding and suspected inherited platelet function disorders and healthy volunteers were recruited to the Genotyping and Phenotyping of Platelets study (GAPP; ISRCTN 77951167). The ISTH-BAT questionnaire was applied by a trained investigator prior to lumiaggregometry.
One hundred participants were included (79 with suspected inherited platelet function disorders, and 21 healthy volunteers). The ISTH-BAT score in participants with suspected inherited platelet function disorders (median 12; interquartile range [IQR] 8-16) was significantly higher than in healthy volunteers (median 0; IQR 0-0). There was no difference between participants with suspected inherited platelet function disorders with a platelet defect detected by lumiaggregometry (median 11; IQR 8-16) and those with normal platelet function (median 12; IQR 8-14) (P > 0.05). The ISTH-BAT score was not associated with a demonstrable platelet defect on platelet function testing (area under the receiver operating characteristic curve = 0.501 [95% confidence interval 0.372-0.630, P = 0.98] and odds ratio 1.01 [95% confidence interval 0.93-1.09, P = 0.91]).
The ISTH-BAT is a powerful tool for documenting lifelong bleeding history. However, the score obtained is not predictive of the presence of a platelet defect on lumiaggregometry in patients with suspected inherited platelet function disorders.
ISTH 出血评估工具(ISTH-BAT)旨在记录出血症状并辅助疑似出血性疾病患者的诊断。
探究 ISTH-BAT 在预测疑似遗传性血小板功能障碍患者血小板激活功能缺陷中的作用。
患者/方法:在怀疑存在遗传性血小板功能障碍并伴有临床明显出血症状的患者和健康志愿者中招募了参加 Genotyping and Phenotyping of Platelets 研究(GAPP;ISRCTN77951167)的参与者。在进行光激聚合试验前,由经过培训的研究者应用 ISTH-BAT 问卷进行评估。
共纳入 100 名参与者(79 名怀疑患有遗传性血小板功能障碍,21 名健康志愿者)。怀疑患有遗传性血小板功能障碍的患者的 ISTH-BAT 评分(中位数 12;四分位距 [IQR]8-16)明显高于健康志愿者(中位数 0;IQR 0-0)(P<0.001)。光激聚合试验检测到血小板缺陷的疑似遗传性血小板功能障碍患者(中位数 11;IQR 8-16)与血小板功能正常的患者(中位数 12;IQR 8-14)的评分无差异(P>0.05)。ISTH-BAT 评分与血小板功能检测中血小板缺陷不相关(受试者工作特征曲线下面积为 0.501 [95%置信区间 0.372-0.630,P=0.98],比值比为 1.01 [95%置信区间 0.93-1.09,P=0.91])。
ISTH-BAT 是记录终生出血史的有力工具。然而,在疑似遗传性血小板功能障碍患者中,该评分不能预测光激聚合试验血小板缺陷的存在。